Tarsus Pharmaceuticals Inc (TARS)

Health Care · Biological Products, (No Diagnostic Substances)

Turbulence: Elevated Sector-strength: 10th pctile calm for sector

Tarsus Pharmaceuticals Inc sits in the Elevated turbulence band, around the 10th percentile of Health Care on balance-sheet strength. The lens reads it as calm for sector. The underlying figures, all from public filings:

Revenue (TTM) $451M
Net income (TTM) $-66M
Operating margin -15.7%
FCF margin -4.9%
Altman Z n/a
Piotroski F 4
Beneish M n/a
Interest coverage -7.943

See the full deep-dive in the app →

Figures from public filings (EDGAR). Descriptive, not advice. No targets, no buy or sell. Price and valuation live in the app.

Get the weekly read by email

The Filter covers the macro backdrop and where balance-sheet strength matters, in the same language as the page above. Descriptive only.

No spam, and the list is never sold or shared. Unsubscribe from any issue.